Editor’s Note. This article presents value-based analyses on the use of Mako robotic technology in total knee, partial knee, and total hip arthroplasty. The authors are with Stryker Orthopaedics in Mahwah, New Jersey.
Joint arthroplasty is an effective procedure to treat advanced osteoarthritis of the hips and knees. It has proven to be successful in reducing pain and restoring function, thereby improving a patient’s quality of life.1 For Medicare beneficiaries, hip and knee replacements are the most common inpatient procedures, with more than 400,000 cases performed in 2014 and costs exceeding $7 billion for hospitalizations alone.2
Multiple orthopedic specialties have adopted robotic technology because of its potential advantages of improved accuracy and reproducibility of component placement, which may reduce outliers and enhance clinical outcomes.3 As healthcare costs continue to increase, a focus on value-based care requires new technologies to be evaluated, not only for their clinical effectiveness but also for their cost-effectiveness.
Robotic-assisted total knee arthroplasty (RA-TKA) with Mako was introduced in 2016 and has since demonstrated improvements in patient outcomes. Cohort studies have shown that patients who underwent RA-TKA reported less postoperative pain, less need for analgesics, fewer physiotherapy sessions, better functional outcome scores, and shorter hospital length of stay (LOS) compared to patients who underwent manual TKA.4-7,38

Figure 1: Medicare 100% Standard Analytical Files were queried for RA-TKA and MTKA cases. Based on propensity-matched cohorts, RA-TKA had (a) reduced episode-of-care cost at 30, 60, and 90 days postoperative as well as (b) reduced rate of readmission at those time points. Mont et al. also observed that (c) RA-TKA patients were more likely to be sent home postoperatively with a health aide or self-care than sent to a skilled nursing facility or inpatient rehab compared to manual.14
Source: Stryker. Used with permission.
Encouraging data at 2-year follow-up show that patients who underwent RA-TKA reported better satisfaction scores compared to patients who underwent manual TKA (MTKA).8-10 A study of Forgotten Joint Scores (FJS), a tool that captures a patient’s ability to forget about their artificial joint in everyday life,11 demonstrated that FJS for RA-TKA patients were on par with or better than their age-matched control US population.12 Although these enhanced clinical benefits look promising, it is equally important to look at the impact of robotic technology on episode-of-care (EOC) costs.
A 90-day EOC cost analysis was performed by Cool et al on TKA procedures performed between January 2016 and March 2017 using a US-based Medicare database. The study, which included 519 RA-TKA and 2,595 MTKA cases that were propensity matched, found that, overall, 90-day EOC costs were $2,391 less for RA-TKA patients. The savings seen among RA-TKA patients were attributed to significantly lower index costs, increased likelihood of being discharged to home rather than to a skilled nursing facility (SNF), and a 33% lower readmission rate.13
Using the same cohort of patients, Mont and colleagues found that RA-TKA was associated with lower 30-, 60-, and 90-day postoperative costs compared to MTKA. At 30 days, they found 47% fewer RA-TKA patients utilized SNF services (13.5% vs 25.4%, P<0.0001) and RA-TKA patients had lower SNF costs at 30, 60, and 90 days. RA-TKA patients also utilized fewer home health visits and incurred fewer costs at each time point ( P<0.05). Additionally, 31.3% fewer RA-TKA patients utilized emergency room services at 30 days postoperatively (Figure 1).14
In a commercially insured population, Pierce et al used the Optum Insights database to look at the 90-day EOC, comparing RA-TKA and MTKA among patients under 65 years of age. They found a significant difference in the 90-day EOC cost.
In this analysis, the RA-TKA arm was $4,049 less expensive per case on average compared to the MTKA procedures ($28,204 vs $32,253; P<0.0001). Contributing to this cost savings were shorter LOS, less likelihood of using inpatient services, and a lower overall post-index cost. They also found that postoperative costs for outpatient therapy and pharmacy were significantly less for RA-TKA compared to MTKA.15
Partial knee arthroplasty (PKA), also known as unicondylar knee arthroplasty (UKA), has been shown in studies to offer reduced tissue disruption, which may lead to greater retention of normal knee kinematics and accelerated postoperative recovery with fewer complications compared to TKA.16
Despite these benefits, PKA can be a technically demanding procedure that is sensitive to implant positioning.17 Malpositioned implants have been associated with early failures. In fact, higher frequencies of revisions and reoperations were seen with PKA in observational and registry-based studies compared to TKA.18
In a study that examined the rate of revisions and associated costs within 24 months of index PKA, Cool and colleagues analyzed robotic-arm assisted PKA (RA-PKA) and manual PKA (MPKA) procedures performed between March 1, 2013, and July 31, 2015, from a US commercial database. After propensity matching to control for confounding factors, a total of 738 patients (246 RA-PKAs, 492 MPKAs) were identified for inclusion in the analysis.
Their results indicated significantly fewer revision procedures in RA-PKA compared to MPKA, 0.81% [2/246] vs 5.28% [26/492]; (P=0.0017), respectively, and RA-PKA patients incurred lower mean costs for the index stay plus revision(s), $26,001 vs $27,977; P>0.05.
Lower LOS at index was also noted in the RA-PKA group, 1.77 vs 2.02 days; P=0.0047. The authors concluded that patients who underwent RA-PKA had fewer revision procedures and shorter LOS, and incurred lower mean costs at 24 months (Table 1).19
Total hip arthroplasty (THA) is considered to be one of the most successful orthopedic procedures. Demand for THA is projected to grow by 174% to 572,000 by 2030.20 Hip revision procedures are also projected to double by 2026.20 Reasons for revisions in THA include malpositioned acetabular components, which may lead to dislocation, impingement, component wear, and liner fracture.21 Robotic-assisted THA with Mako has been shown in studies to help surgeons accurately position acetabular components, as well as reduce blood loss and early dislocation.22, 28-32
Looking at index cost and post discharge utilization, Pierce and colleagues compared 90-day EOC costs for 938 robotic-arm assisted THA (RA-THA) patients to 4,670 manual THA (MTHA) patients from the Medicare 100% Standard Analytical Files. They found that RA-THA patients were less likely to have post-index inpatient rehabilitation or SNF admissions, used fewer days in post-index inpatient and SNF care, and used fewer home health aide visits compared to MTHA patients.
Overall, RA-THA patients had 12% ($948) lower average post-index costs compared to MTHA patients (P=0.0004). Total average 90-day EOC costs for RA-THA patients were found to be $785 less than those of MTHA patients ($19,734 vs $20,519, P=0.0095). The cost savings seen with RA-THA were driven by reduced healthcare utilization and reduced cost of post-index rehabilitation services.23
This review shows that robotic-arm assisted arthroplasty with Mako has improved clinical outcomes and reduced EOC costs and health services utilization in PKA, TKA, and THA compared to manual techniques. This demonstrates Mako’s potential to deliver value to patients, providers, and payers alike. ✥
1. Ethgen O, Bruyère O, Richy F, et al. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am. 2004;86(5):963-974.
2. Comprehensive Care for Joint Replacement Model. https://innovation.cms.gov/innovation-models/cjr.
3. Chen A F, Kazarian G S, Jessop G W, et al. Robotic technology in orthopaedic surgery. J Bone Joint Surg Am. 2018;100:1984-1992.
4. Kayani B, Konan S, Tahmassebi J, et al. Robotic-arm assisted total knee arthroplasty is associated with improved early functional recovery and reduced time to hospital discharge compared with conventional jig-based total knee arthroplasty: A prospective cohort study. Bone Joint J. 2018;100-B(7):930-937.
5. Barga K. Less pain and less opioid use reported postoperatively in patients undergoing haptic guided, robotic arm–assisted total knee arthroplasty (RATKA). OR Manager Conference. 2019.
6. Greiner J J, Wang J F, Mitchell J, et al. Opioid use in robotic-arm assisted total knee arthroplasty: A comparison to conventional manual total knee arthroplasty. Surg Technol Int. 2020;28(37):280-289.
7. Khlopas A, Sodhi N, Hozack W J, et al. Patient-reported functional and satisfaction outcomes after robotic-arm-assisted total knee arthroplasty: Early results of a prospective multicenter investigation. J Knee Surg. 2020;33(7):685-690.
8. Smith A F, Eccles C J, Bhimani S J, et al. Improved patient satisfaction following robotic-assisted total knee arthroplasty. J Knee Surg. Published online November 15, 2019.
9. Marchand R, Marchand K, Taylor K B, et al. Patient satisfaction after CT based robotic-assisted total knee arthroplasty. Annual Orthopaedic Research Society Meeting. 2020.
10. Malkani A L, Roche M W, Kolisek F R, et al. New technology for total knee arthroplasty provides excellent patient-reported outcomes: A minimum two-year analysis. Surg Technol Int. 2020;28(36):276-280.
11. Giesinger J M, Behrend H, Hamilton D F, et al. Normative values for the Forgotten Joint Score-12 for the US general population. J Arthroplasty. 2019;34(4):650-655.
12. Scholl L, Barga K, Bhowmik-Stoker M. Two-year forgotten joint score following robotic total knee arthroplasty: A multicenter assessment. 2020 OR Manager Virtual Conference.
13. Cool C L, Jacofsky D J, Seeger K A, et al. A 90-day episode-of-care cost analysis of robotic-arm assisted total knee arthroplasty. J Comp Eff Res. 2019;8(5):327-336.
14. Mont M A, Cool C, Gregory D, et al. Health care utilization and payer cost analysis of robotic arm assisted total knee arthroplasty at 30, 60, and 90 days. J Knee Surg. Published online September 2, 2019.
15. Pierce J, Needham C, Adams C, et al. Robotic-assisted knee surgery: An economic analysis. Orthopaedic Research Society Annual Meeting. 2020.
16. Jennings J M, Kleeman-Forsthuber L T, Bolognesi M P. Medial unicompartmental arthroplasty of the knee. J Am Acad Orthop Surg. 2019;27(5):166-176.
17. Bell S W, Anthony I, Jones B, et al. Improved accuracy of component positioning with robotic-assisted unicompartmental knee arthroplasty: Data from a prospective, randomized controlled study. J Bone Joint Surg Am. 2016;98(8):627-635.
18. Beard D J, Davies L J, Cook, J A, et al. The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial. Lancet. 2019;394(10200):746-756.
19. Cool C L, Needham K A, Khlopas A, et al. Revision analysis of robotic arm-assisted and manual unicompartmental knee arthroplasty. J Arthroplasty. 2019;34(5):926-931.
20. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780-785.
21. Callanan M C, Jarrett B, Bragdon C R, et al. The John Charnley Award: Risk factors for cup malpositioning: Quality improvement through a joint registry at a tertiary hospital. Clin Orthop Relat Res. 2011;469(2):319-329.
22. Illgen R L, Bukowski B R, Abiola R, et al. Robotic-assisted total hip arthroplasty: Outcomes at minimum two year follow up. Surg Technol Int. 2017;30:365-372.
23. Pierce J, Needham K, Adams C, et al. Robotic assisted total hip arthroplasty: A 90-day episode of care cost analysis. The Professional Society for Health Economics and Outcomes Research (ISPOR) Annual Meeting. 2020.
24. Park K K, Han C D, Yang I-H, et al. Robot-assisted unicompartmental knee arthroplasty can reduce radiologic outliers compared to conventional techniques. PLoS ONE. 2019;14(12): e0225941. https://doi.org/10.1371/journal.pone.0225941.
25. Kleeblad L J, Borus T A, Coon T M, et al. Midterm survivorship and patient satisfaction of robotic-arm-assisted medial unicompartmental knee arthroplasty: A multicenter study. J Arthroplasty. 2018;33(6):1719-1726.
26. Dretakis K, Igoumenou V G. Outcomes of robotic-arm-assisted medial unicompartmental knee arthroplasty: Minimum 3-year follow-up. Eur J Orthop Surg Traumatol. 2019;29(6):1305-1311.
27. Gilmour A, MacLean A D, Rowe P J, et al. Robotic-arm-assisted vs conventional unicompartmental knee arthroplasty. The 2-year clinical outcomes of a randomized controlled trial. J Arthroplasty. 2018;33(7S):S109-S115.
28. Elson L, Dounchis J, Illgen R, et al. Precision of acetabular cup placement in robotic integrated total hip arthroplasty. Hip Int. 2015;25(6):531-536.
29. Domb B G, Redmond J M, Louis S S, et al. Accuracy of component positioning in 1980 total hip arthroplasties: A comparative analysis by surgical technique and mode of guidance. J Arthroplasty. 2015;30(12):2208-2018.
30. Bukowski B R, Anderson P, Khlopas A, et al. Improved functional outcomes with robotic compared with manual total hip arthroplasty. Surg Technol Int. 2016;29:303-308.
31. Domb B G, Chen J W, Lall A C, et al. Minimum 5-year outcomes of robotic-assisted primary total hip arthroplasty with a nested comparison against manual primary total hip arthroplasty: A propensity score-matched study. J Am Acad Orthop Surg. 2020;28(20):847-856.
32. Perets I, Walsh J P, Close M R, et al. Robot-assisted total hip arthroplasty: Clinical outcomes and complication rate. Int J Med Robot; 2018;14(4):e1912.
33. Bourne R B, Chesworth B M, Davis A M, et al. Patient satisfaction after total knee arthroplasty: Who is satisfied and who is not? Clin Orthop Relat Res. 2010;468(1):57-63.
34. Khlopas A, Chughtai M, Hampp E L, et al. Robotic-arm assisted total knee arthroplasty demonstrated soft tissue protection. Surg Technol Int. 2017;30:441-446.
35. Kayani B, Konan S, Pietrzak J R T, et al. Iatrogenic bone and soft tissue trauma in robotic-arm assisted total knee arthroplasty compared with conventional jig-based total knee arthroplasty: A prospective cohort study and validation of a new classification system. J Arthroplasty. 2018;33(8):2496-2501.
36. Mahoney O, Kinsey T, Sodhi N, et al. Improved component placement accuracy with robotic-arm assisted total knee arthroplasty. J Knee Surg. Published online August 31, 2020.
37. Malkani A L, Roche M, Kolisek F R, et al. Manipulation under anesthesia rates in technology-assisted versus conventional-instrumentation total knee arthroplasty. Surg Technol Int. 2020;36:336-340.
38. Bhimani S J, Bhimani R, Smith A, et al. Robotic assisted total knee arthroplasty demonstrates decreased postoperative pain and opioid usage compared to conventional total knee arthroplasty. Bone Jt Open. 2020;1(2):8-12.
39. Cotter E J, Wang J, Illgen R L. Comparative cost analysis of robotic-assisted and jig-based manual primary total knee arthroplasty. J Knee Surg. Published online July 13, 2020.
40. Marchand R C, Sodhi N, Anis H K, et al. One-year patient outcomes for robotic-arm-assisted versus manual total knee arthroplasty. J Knee Surg. 2019;32(11):1063-1068.
41. Kayani B, Konan S, Tahmassebi J, et al. An assessment of early functional rehabilitation and hospital discharge in conventional versus robotic-arm assisted unicompartmental knee arthroplasty: A prospective cohort study. Bone Joint J. 2019;101-B(1):24-33.
42. Marchand R C, Sodhi N, Khlopas A, et al. Patient satisfaction outcomes after robotic arm-assisted total knee arthroplasty: A short-term evaluation. J Knee Surg. 2017;30(9):849-853.
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Mako, Stryker. All other trademarks are trademarks of their respective owners or holders.